Evidence map›Paper›PMID 41504443›Full record

ArticleJournal of virology2026

Structural insights into a broadly reactive nanobody that binds pathogenic and non-pathogenic lagoviruses.

Derin Kara, Marie Pancera, Gholamreza Hassanzadeh-Ghassabeh, Steve Schoonooghe, Veronika Masic, Lauren Hartley-Tassell, Biswa Prasanna Mishra, Thomas Ve, Thomas Haselhorst, Mark von Itzstein and 1 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Derin KaraVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Marie PanceraVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Gholamreza Hassanzadeh-GhassabehVIB Nanobody VHH Core, Vrije Universiteit Brussel, Brussels, Belgium.
Steve SchoonoogheVIB Nanobody VHH Core, Vrije Universiteit Brussel, Brussels, Belgium.
Veronika MasicInstitute for Biomedicine and Glycomics, Griffith University, Gold Coast Campus, Gold Coast, Queensland, Australia.
Lauren Hartley-TassellInstitute for Biomedicine and Glycomics, Griffith University, Gold Coast Campus, Gold Coast, Queensland, Australia.
Biswa Prasanna MishraInstitute for Biomedicine and Glycomics, Griffith University, Gold Coast Campus, Gold Coast, Queensland, Australia.
Thomas VeInstitute for Biomedicine and Glycomics, Griffith University, Gold Coast Campus, Gold Coast, Queensland, Australia.
Thomas HaselhorstInstitute for Biomedicine and Glycomics, Griffith University, Gold Coast Campus, Gold Coast, Queensland, Australia.
Mark von ItzsteinInstitute for Biomedicine and Glycomics, Griffith University, Gold Coast Campus, Gold Coast, Queensland, Australia.ORCID 0000-0001-6302-7524
Grant S HansmanInstitute for Biomedicine and Glycomics, Griffith University, Gold Coast Campus, Gold Coast, Queensland, Australia.ORCID 0000-0001-8735-4618

Funding

Australian Synchrotron 24070Griffith University
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

calicivirusnanobodyX-ray crystallography

Identifiers

PMID41504443
PMCPMC12911892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.